|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: LARGE SCALE BIOLOGY CORP, 10-Q, 2000-11-14 |
Next: ENTRAVISION COMMUNICATIONS CORP, 10-Q, 2000-11-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY INCLUDED IN ITS
FORM 10-Q FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED
IN ITS ENTIRETY BY REFERENCE TO SUCH FORM 10-Q
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 56,675
<SECURITIES> 34,070
<RECEIVABLES> 1,738
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 93,667
<PP&E> 16,883
<DEPRECIATION> (7,766)
<TOTAL-ASSETS> 109,952
<CURRENT-LIABILITIES> 16,827
<BONDS> 1,391
0
0
<COMMON> 189,662
<OTHER-SE> (98,760)
<TOTAL-LIABILITY-AND-EQUITY> 109,952
<SALES> 0
<TOTAL-REVENUES> 17,572
<CGS> 0
<TOTAL-COSTS> 31,625
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 276
<INCOME-PRETAX> (14,039)
<INCOME-TAX> 0
<INCOME-CONTINUING> (14,039)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (14,039)
<EPS-BASIC> 1.15
<EPS-DILUTED> 1.15
</TABLE>
|
|